| 标题 |
Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet 作者:Hong S, Zhou T, Hou X, Meng X, Hu Z, Zheng W, Cui J, Luo Y, Wu L, Huang M, Xu H, Hu J, Zhao Y, Yao W, Hong Y, Cai J, Zhang Y, Su C, Xie C, Wang R, Li X, He Q, Zhang L, Ning R, Lin D, Zhang T, Yi T, Zhong L, Huang S, Zhao H, Fang J, Bu Q, Li B, Zhang Z, Shi M, Shi J, Deng Z, Zhu Y, Zhu H, Xiao S, Yang L, Song N, Fang W, Zhang L, Yang Y, PANKU-Lung01 Investigators 出版日期:2026-10-26 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)